|
1
|
Karatzanis AD, Psychogios G, Zenk J,
Waldfahrer F, Hornung J, Velegrakis GA and Iro H: Comparison among
different available surgical approaches in T1 glottic cancer.
Laryngoscope. 119:1704–1708. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lebedeva IV, Sauane M, Gopalkrishnan RV,
et al: MDA-7/IL-24: exploiting cancer’s Achilles’ heel. Mol Ther.
11:4–18. 2005.
|
|
3
|
Gupta P, Su ZZ, Lebedeva IV, et al:
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing
cytokine. Pharmacol Ther. 111:596–628. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fisher PB: Is mda-7/IL-24 a ‘magic bullet’
for cancer? Cancer Res. 65:10128–10138. 2005.
|
|
5
|
Jiang H, Lin JJ, Su ZZ, Goldstein NI and
Fisher PB: Subtraction hybridization identifies a novel melanoma
differentiation associated gene, mda-7, modulated during human
melanoma differentiation, growth and progression. Oncogene.
11:2477–2486. 1995.
|
|
6
|
Wei N, Fan JK, Gu JF and Liu XY:
Double-regulated oncolytic adenovirus-mediated interleukin-24
overexpression exhibits potent antitumor activity on gastric
adenocarcinoma. Hum Gene Ther. 21:855–864. 2010. View Article : Google Scholar
|
|
7
|
Huang EY, Madireddi MT, Gopalkrishnan RV,
et al: Genomic structure, chromosomal localization and expression
profile of a novel melanoma differentiation associated (mda-7) gene
with cancer specific growth suppressing and apoptosis inducing
properties. Oncogene. 20:7051–7063. 2001. View Article : Google Scholar
|
|
8
|
Sauane M, Gupta P, Lebedeva IV, et al:
N-glycosylation of MDA-7/IL-24 is dispensable for tumor
cell-specific apoptosis and ‘bystander’ antitumor activity. Cancer
Res. 66:11869–11877. 2006.PubMed/NCBI
|
|
9
|
Jiang H, Su ZZ, Lin JJ, Goldstein NI,
Young CS and Fisher PB: The melanoma differentiation associated
gene mda-7 suppresses cancer cell growth. Proc Natl Acad Sci USA.
93:9160–9165. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tian Z, Shen X, Feng H and Gao B: IL-1
beta attenuates IFN-alpha beta-induced antiviral activity and STAT1
activation in the liver: involvement of proteasome- dependent
pathway. J Immunol. 165:3959–3965. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maarof G, Bouchet-Delbos L, Gary-Gouy H,
Durand-Gasselin I, Krzysiek R and Dalloul A: Interleukin-24
inhibits the plasma cell differentiation program in human germinal
center B cells. Blood. 115:1718–1726. 2010. View Article : Google Scholar
|
|
12
|
Ekmekcioglu S, Ellerhorst J, Mhashilkar
AM, et al: Down-regulated melanoma differentiation associated gene
(mda-7) expression in human melanomas. Int J Cancer. 94:54–59.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ellerhorst JA, Prieto VG, Ekmekcioglu S,
Broemeling L, Yekell S, Chada S and Grimm EA: Loss of MDA-7
expression with progression of melanoma. J Clin Oncol.
20:1069–1074. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su ZZ, Madireddi MT, Lin JJ, et al: The
cancer growth suppressor gene mda-7 selectively induces apoptosis
in human breast cancer cells and inhibits tumor growth in nude
mice. Proc Natl Acad Sci USA. 95:14400–14405. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saeki T, Mhashilkar A, Chada S, Branch C,
Roth JA and Ramesh R: Tumor-suppressive effects by
adenovirus-mediated mda-7 gene transfer in non-small cell lung
cancer cell in vitro. Gene Ther. 7:2051–2057. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Madireddi MT, Su ZZ, Young CS, Goldstein
NI and Fisher PB: Mda-7, a novel melanoma differentiation
associated gene with promise for cancer gene therapy. Adv Exp Med
Biol. 465:239–261. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lebedeva IV, Su ZZ, Chang Y, Kitada S,
Reed JC and Fisher PB: The cancer growth suppressing gene mda-7
induces apoptosis selectively in human melanoma cells. Oncogene.
21:708–718. 2002. View Article : Google Scholar
|
|
18
|
Su ZZ, Lebedeva IV, Sarkar D, et al:
Melanoma differentiation associated gene-7, mda-7/IL-24,
selectively induces growth suppression, apoptosis and
radiosensitization in malignant gliomas in a p53-independent
manner. Oncogene. 22:1164–1180. 2003. View Article : Google Scholar
|
|
19
|
Lebedeva IV, Su ZZ, Vozhilla N, et al:
Mechanism of in vitro pancreatic cancer cell growth inhibition by
melanoma differentiation-associated gene-7/interleukin-24 and
perillyl alcohol. Cancer Res. 68:7439–7447. 2008. View Article : Google Scholar
|
|
20
|
Fisher PB, Gopalkrishnan RV, Chada S, et
al: mda-7/IL-24, a novel cancer selective apoptosis inducing
cytokine gene: from the laboratory into the clinic. Cancer Biol
Ther. 2(4 Suppl 1): S23–S37. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cunningham CC, Chada S, Merritt JA, et al:
Clinical and local biological effects of an intratumoral injection
of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a
phase I study. Mol Ther. 11:149–159. 2005. View Article : Google Scholar
|
|
22
|
Tong AW, Nemunaitis J, Su D, et al:
Intratumoral injection of INGN 241, a nonreplicating adenovector
expressing the melanoma-differentiation associated gene-7
(mda-7/IL24): biologic outcome in advanced cancer patients. Mol
Ther. 11:160–172. 2005. View Article : Google Scholar
|
|
23
|
Su ZZ, Lebedeva IV, Sarkar D, et al:
Ionizing radiation enhances therapeutic activity of mda-7/IL-24:
overcoming radiation and mda-7/IL-24-resistance in prostate cancer
cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2.
Oncogene. 25:2339–2348. 2006. View Article : Google Scholar
|
|
24
|
Park MA, Walker T, Martin AP, et al:
MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells
occurs by a ceramide/CD95/PERK-dependent mechanism. Mol Cancer
Ther. 8:1280–1291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eulitt PJ, Park MA, Hossein H, et al:
Enhancing mda-7/IL-24 therapy in renal carcinoma cells by
inhibiting multiple protective signaling pathways using sorafenib
and by Ad.5/3 gene delivery. Cancer Biol Ther. 10:1290–1305. 2010.
View Article : Google Scholar
|
|
26
|
Ramesh R, Mhashilkar AM, Tanaka F, et al:
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a
novel ligand that regulates angiogenesis via the IL-22 receptor.
Cancer Res. 63:5105–5113. 2003.
|
|
27
|
Chada S, Mhashilkar AM, Liu Y, et al:
mda-7 gene transfer sensitizes breast carcinoma cells to
chemotherapy, biologic therapies and radiotherapy: correlation with
expression of bcl-2 family members. Cancer Gene Ther. 13:490–502.
2006. View Article : Google Scholar
|
|
28
|
Cosetti M, Yu GP and Schantz SP: Five-year
survival rates and time trends of laryngeal cancer in the US
population. Arch Otolaryngol Head Neck Surg. 134:370–379. 2008.
|
